G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,409 | +8.3% | 105,385 | +136.3% | 0.01% | -23.1% |
| Q4 2022 | $242,194 | -50.9% | 44,603 | +12.9% | 0.01% | -31.6% |
| Q3 2022 | $493,000 | +142.9% | 39,500 | -3.8% | 0.02% | +111.1% |
| Q2 2022 | $203,000 | +2.5% | 41,054 | +111.6% | 0.01% | -25.0% |
| Q4 2021 | $198,000 | -73.4% | 19,400 | -42.8% | 0.01% | -83.3% |
| Q2 2021 | $744,000 | +107.2% | 33,902 | +8.9% | 0.07% | 0.0% |
| Q3 2020 | $359,000 | – | 31,124 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |